Tag: Jim Potter

Jim Potter

Data Privacy

CHC & 4A’s Member-Exclusive HIPAA Guidance

CHC & 4A’s Member-Exclusive HIPAA Guidance

CHC & 4A’s Member-Exclusive Guidance Crafted jointly by the CHC and 4A’s, this first-of-its-kind industry guidance – Navigating the Health Data Privacy Landscape: A Guide for Agencies – is designed to help partner healthcare agencies and communications companies better understand health data privacy compliance given the new wave of laws and regulations cropping up around […]

Read more

Data Privacy

HHS-OCR & NIST Release Joint HIPAA Resource Guidance

HHS-OCR & NIST Release Joint HIPAA Resource Guidance

The HHS Office for Civil Rights (OCR) and the National Institute of Standards and Technology (NIST) published the final version of Special Publication (SP) 800-66 Revision 2, aimed at helping covered entities and business associates better understand and comply with the HIPAA Security Rule. The final version serves as a resource guide and maps the […]

Read more

Regulatory/FDA

Current FDA Voluntary Pre-Publication Rx Ad Review Processes

Current FDA Voluntary Pre-Publication Rx Ad Review Processes

As run-up to FDA’s DTC Prescription Advertising Rule that goes into effect on May 20, 2024, CHC is working with FDA staff to help reinforce current ad review processes available to healthcare marketers and how review of ads will change in May and later this year with its November enforcement date. Watch for our planned […]

Read more

Courts/First Amendment

CHC brief questions FTC ad market definition in IQVIA merger challenge

CHC brief questions FTC ad market definition in IQVIA merger challenge

WASHINGTON, DC – The Coalition for Healthcare Communication (CHC) has filed a federal court amicus brief that raises concerns about how the Federal Trade Commission (FTC) defined the “programmatic advertising” marketplace in its complaint against IQVIA’s proposed merger with Propel Media and offered its real-world insight into the industry, which span the entire digital “ad […]

Read more

DTC Advertising

FDA Issues Long-Awaited Final Rule for DTC Prescription Drug Ads

FDA Issues Long-Awaited Final Rule for DTC Prescription Drug Ads

The FDA’s final rule for Direct-to-Consumer Prescription Drug Advertisements (released on November 21, 2023) will certainly impact the creative decisions agencies will make about how to structure the agency refers to as the “major statement” or the dual modality of presenting in a balanced or “neutral” manner the drug’s benefits and risks in visually clear, […]

Read more

Regulatory/FDA

FTC Releases New Staff Paper on Harms to Kids & Teens from Online “Blurred” or Stealth Advertising

FTC Releases New Staff Paper on Harms to Kids & Teens from Online “Blurred” or Stealth Advertising

The Federal Trade Commission (FTC) issued a new staff paper in conjunction with their open Commission meeting that recommends that advertisers, social media influencers, and others who market or promote products online to children should avoid blurring advertising by clearly separating advertising and entertainment, educational, and other content to help limit potential negative effects to […]

Read more

Data Privacy

California AG Investigates Large Employers for CCPA Employee Data Compliance

California AG Investigates Large Employers for CCPA Employee Data Compliance

California Attorney General Rob Bonta announced on July 14th an investigative sweep with written inquiry letters sent to large California employers requesting information regarding the companies’ compliance with the employee data provisions of the California Consumer Privacy Act (CCPA). AG Bonta’s letters specifically address businesses’ compliance with the CCPA’s legal protections governing the handling of […]

Read more

Regulatory/FDA

FTC Issues Proposed Rule Identifying 7 Deceptive Marketing Review and Testimonial Practices

FTC Issues Proposed Rule Identifying 7 Deceptive Marketing Review and Testimonial Practices

The Federal Trade Commission (FTC) announced on June 30th a new notice of proposed rulemaking (NPRM) that attempts to stop marketers from using illicit or deceptive review and endorsement practices. This proposed rule aims to protect consumers seeking genuine feedback on products and services while promoting fairness for honest businesses. Any agencies or their clients […]

Read more

Regulatory/FDA

FTC Releases First Update to Endorsement Ad Guidelines in a Decade

FTC Releases First Update to Endorsement Ad Guidelines in a Decade

The Federal Trade Commission (FTC) issued updates on June 29, 2023 to its Guides Concerning the Use of Endorsements and Testimonials in Advertising (“Endorsement Guides”) and updated its practical business guidance “FTC’s Endorsement Guides: What People are Asking” (“Business Guidance”). Last updated in 2009, the final revisions to the Endorsement Guides feature several key additions addressing technological changes in […]

Read more